Arteris, Inc. (NASDAQ:AIP – Get Free Report) CFO Nicholas B. Hawkins sold 14,387 shares of the company’s stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $11.15, for a total value of $160,415.05. Following the sale, the chief financial officer now owns 169,868 shares of the company’s stock, valued at approximately $1,894,028.20. The trade was a 7.81 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.
Arteris Stock Performance
Shares of AIP stock opened at $11.25 on Thursday. The company has a current ratio of 1.16, a quick ratio of 1.16 and a debt-to-equity ratio of 0.30. The company has a market cap of $451.99 million, a PE ratio of -11.72 and a beta of 1.17. The company’s fifty day simple moving average is $9.08 and its 200-day simple moving average is $8.11. Arteris, Inc. has a 52 week low of $4.83 and a 52 week high of $12.64.
Analyst Upgrades and Downgrades
Separately, Rosenblatt Securities restated a “buy” rating and set a $15.00 price target on shares of Arteris in a research note on Wednesday, November 6th.
Institutional Inflows and Outflows
Hedge funds have recently added to or reduced their stakes in the stock. State Street Corp grew its stake in shares of Arteris by 18.5% in the third quarter. State Street Corp now owns 410,578 shares of the company’s stock valued at $3,170,000 after buying an additional 64,081 shares in the last quarter. Bank of New York Mellon Corp purchased a new position in Arteris in the 2nd quarter worth approximately $580,000. Dynamic Technology Lab Private Ltd acquired a new stake in Arteris in the third quarter valued at approximately $226,000. Geode Capital Management LLC raised its stake in shares of Arteris by 6.6% during the third quarter. Geode Capital Management LLC now owns 597,116 shares of the company’s stock valued at $4,610,000 after purchasing an additional 36,908 shares during the period. Finally, Barclays PLC lifted its position in shares of Arteris by 321.1% during the third quarter. Barclays PLC now owns 39,396 shares of the company’s stock worth $304,000 after purchasing an additional 30,041 shares in the last quarter. 64.36% of the stock is owned by hedge funds and other institutional investors.
About Arteris
Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.
See Also
- Five stocks we like better than Arteris
- What is Forex and How Does it Work?
- Moderna Shares Spike on H5N1 News—What’s Next for Investors?
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Nebius Group (NBIS): A Small-Cap Backed by NVIDIA
- Expert Stock Trading Psychology Tips
- Natural Gas Demand to Surge: Top 3 Stocks and ETFs to Consider
Receive News & Ratings for Arteris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arteris and related companies with MarketBeat.com's FREE daily email newsletter.